Results 221 to 230 of about 1,010,447 (365)
Afghanistan: A Glimpse of War—Contemporary History at the Canadian War Museum [PDF]
, 2012 How do you exhibit the history of an ongoing conflict, with an unknown outcome and with most documents restricted on the basis of operational security? What story can you tell?
Burtch, Andrew
core +1 more source
A Method of Preserving the Green Color of Plants for Exhibition Purposes
, 1897 Albert F. Woods
openalex +2 more sources
"Analogies between the phosphorized fats obtained from the brain and kidney," with exhibition of products [PDF]
, 1904 Edward K. Dunham
openalex +1 more source
Molecular Oncology, EarlyView.Pancreatic ductal adenocarcinoma (PDAC) is a disease with very poor prognosis due to therapeutic limitations. We investigated the antitumor effects of cystatin A (CSTA) in PDAC murine models. We are first to confirm that CSTA enhances T helper type 1‐mediated antitumor effects through promotion of dendritic cells and M1 macrophage activity. CSTA can be
Alessandro Nasti +8 more
wiley +1 more source
Extirpation of both kidneys from a cat and transplantation of both kidneys from another cat, with exhibition of specimens [PDF]
, 1906 Alexis Carrel
openalex +1 more source
Molecular Oncology, EarlyView.Prostate cancer is a leading malignancy with significant clinical heterogeneity in men. An 11‐gene signature derived from dysregulated epithelial cell markers effectively predicted biochemical recurrence‐free survival in patients who underwent radical surgery or radiotherapy.
Zhuofan Mou, Lorna W. Harries
wiley +1 more source
Molecular Oncology, EarlyView.The complex mode of action of the topoisomerase II inhibitor etoposide in triggering apoptosis involves several mechanisms: overexpression of the mitochondrial protein VDAC1, leading to its oligomerization and formation of a large channel that mediates the release of pro‐apoptotic protein; and overexpression of the apoptosis regulators p53, Bax, and ...
Aditya Karunanithi Nivedita +1 more
wiley +1 more source
Molecular Oncology, EarlyView.Using mass cytometry, we analyzed serial blood samples from patients with relapsed epithelial ovarian cancer (EOC) treated with oleclumab–durvalumab combination immunotherapy in the NSGO‐OV‐UMB1/ENGOT‐OV30 trial. Our analysis identified potential predictive, monitoring, and response biomarkers detectable through liquid biopsy. These findings facilitate
Luka Tandaric +11 more
wiley +1 more source